Clopidogrel-induced mixed hepatocellular and cholestatic liver injury

Howard J. Willens

doi:10.1097/00045391-200007050-00009

Clopidogrel-induced mixed hepatocellular and cholestatic liver injury

Howard J. Willens

Medicine

Research output: Contribution to journal › Article › peer-review

28 Scopus citations

Abstract

An 81-year-old woman developed symptomatic liver disease 3 weeks after beginning clopidogrel as adjunctive antiplatelet therapy for a coronary stent implantation. Symptomatic liver disease associated with short-term periprocedural administration of clopidogrel for coronary stenting has not been well described. The clinical significance of this event as well as a possible interaction between clopidogrel and other drugs metabolized by the cytochrome P450 2C9 pathways coadministered to this patient are discussed.

Original language	English (US)
Pages (from-to)	317-318
Number of pages	2
Journal	American journal of therapeutics
Volume	7
Issue number	5
DOIs	https://doi.org/10.1097/00045391-200007050-00009
State	Published - Jan 1 2000

Keywords

Clopidogrel
Drug-induced hepatotoxicity

ASJC Scopus subject areas

Pharmacology

Access to Document

10.1097/00045391-200007050-00009

Fingerprint Dive into the research topics of 'Clopidogrel-induced mixed hepatocellular and cholestatic liver injury'. Together they form a unique fingerprint.

Cite this

@article{ed65f33d6eb843f68455da095eee171c,

title = "Clopidogrel-induced mixed hepatocellular and cholestatic liver injury",

abstract = "An 81-year-old woman developed symptomatic liver disease 3 weeks after beginning clopidogrel as adjunctive antiplatelet therapy for a coronary stent implantation. Symptomatic liver disease associated with short-term periprocedural administration of clopidogrel for coronary stenting has not been well described. The clinical significance of this event as well as a possible interaction between clopidogrel and other drugs metabolized by the cytochrome P450 2C9 pathways coadministered to this patient are discussed.",

keywords = "Clopidogrel, Drug-induced hepatotoxicity",

author = "Willens, {Howard J.}",

year = "2000",

month = jan,

day = "1",

doi = "10.1097/00045391-200007050-00009",

language = "English (US)",

volume = "7",

pages = "317--318",

journal = "American Journal of Therapeutics",

issn = "1075-2765",

publisher = "Lippincott Williams and Wilkins",

number = "5",

}

TY - JOUR

T1 - Clopidogrel-induced mixed hepatocellular and cholestatic liver injury

AU - Willens, Howard J.

PY - 2000/1/1

Y1 - 2000/1/1

N2 - An 81-year-old woman developed symptomatic liver disease 3 weeks after beginning clopidogrel as adjunctive antiplatelet therapy for a coronary stent implantation. Symptomatic liver disease associated with short-term periprocedural administration of clopidogrel for coronary stenting has not been well described. The clinical significance of this event as well as a possible interaction between clopidogrel and other drugs metabolized by the cytochrome P450 2C9 pathways coadministered to this patient are discussed.

AB - An 81-year-old woman developed symptomatic liver disease 3 weeks after beginning clopidogrel as adjunctive antiplatelet therapy for a coronary stent implantation. Symptomatic liver disease associated with short-term periprocedural administration of clopidogrel for coronary stenting has not been well described. The clinical significance of this event as well as a possible interaction between clopidogrel and other drugs metabolized by the cytochrome P450 2C9 pathways coadministered to this patient are discussed.

KW - Clopidogrel

KW - Drug-induced hepatotoxicity

UR - http://www.scopus.com/inward/record.url?scp=0034278708&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034278708&partnerID=8YFLogxK

U2 - 10.1097/00045391-200007050-00009

DO - 10.1097/00045391-200007050-00009

M3 - Article

C2 - 11317178

AN - SCOPUS:0034278708

VL - 7

SP - 317

EP - 318

JO - American Journal of Therapeutics

JF - American Journal of Therapeutics

SN - 1075-2765

IS - 5

ER -